M.R.L.41 in the treatment of secondary amenorrhoea and endometrial hyperplasia

Lancet (London, England), 2(7250), 278-280

DOI 10.1016/s0140-6736(62)90178-2 PMID 13878270 Source

No abstract available for this article.

secondary amenorrhea treatment, endometrial hyperplasia therapy, absent menstrual periods medication, thickened uterine lining treatment, menstrual cycle disorders pharmacological

Charles D (1962). M.R.L.41 in the treatment of secondary amenorrhoea and endometrial hyperplasia. *Lancet (London, England)*, *2*(7250), 278-280. https://doi.org/10.1016/s0140-6736(62)90178-2